Tango Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €36.29M +15.2% -€112.40M +28.1% -309.7% -0.31 pp -€112.78M +12.3% -310.8% +0.080 pp
    €31.51M +46.9% -€87.76M -5.9% -278.5% +1.6 pp -€100.45M +14.9% -318.8% +0.89 pp
    €21.44M -32.9% -€93.31M +85.8% -435.1% -2.8 pp -€87.46M +75.7% -407.8% -2.5 pp
    €31.95M +383.8% -€50.23M +12.3% -157.2% +5.2 pp -€49.76M -181.0% -155.7% -11 pp
    €6.60M -68.9% -€44.74M +268.0% -677.4% -6.2 pp €61.40M -409.7% 929.7% +10 pp
    €21.26M -€12.16M -57.2% -€19.83M -93.3%

    Notifications